Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovex International, Inc. filings document formal disclosures for an oil and gas well-products company formed from the Dril-Quip and Innovex Downhole Solutions merger. Recent 8-K reports furnish quarterly results, earnings presentations and non-GAAP reconciliations, while proxy materials cover annual meeting matters, board governance and executive compensation.
The filing record also includes material-event disclosures on common-stock offering agreements by selling stockholders, share repurchase activity under the company's repurchase program, director changes and litigation involving Downhole Well Solutions, LLC, a wholly owned subsidiary, and friction-reduction tools used in directional drilling.
Innovex International, Inc. is registering the resale of 5,750,000 shares of its common stock by selling stockholders as set forth in a preliminary prospectus supplement dated February 25, 2026. The Company will receive no proceeds from these sales and has agreed to register up to 29,369,822 shares for resale under the base prospectus.
The prospectus supplement states the Company intends, subject to completion of the offering, to repurchase the lesser of 10% of the offered shares or $15,000,000 (which would equal 575,000 shares if repurchasing 10%). Shares outstanding were 69,138,690 shares as of February 24, 2026. The underwriters have a 30‑day option to purchase additional shares and lock-up and registration‑rights provisions apply to the selling stockholders and certain insiders.
Innovex International, Inc. is registering the resale of 5,750,000 shares of its common stock by selling stockholders as set forth in a preliminary prospectus supplement dated February 25, 2026. The Company will receive no proceeds from these sales and has agreed to register up to 29,369,822 shares for resale under the base prospectus.
The prospectus supplement states the Company intends, subject to completion of the offering, to repurchase the lesser of 10% of the offered shares or $15,000,000 (which would equal 575,000 shares if repurchasing 10%). Shares outstanding were 69,138,690 shares as of February 24, 2026. The underwriters have a 30‑day option to purchase additional shares and lock-up and registration‑rights provisions apply to the selling stockholders and certain insiders.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of company stock. On February 23, 2026, he sold 13,241 shares of common stock at $27.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
After this transaction, Anderson directly owned 485,581 shares of Innovex International common stock. The filing specifies that all shares in this trade were sold at the stated price per share.
Innovex International, Inc. files its annual report describing a larger, more diversified oilfield technology business following a merger and several acquisitions. Legacy Innovex merged with Dril-Quip and the combined company bought majority stakes in Downhole Well Solutions, SCF Machining and Citadel Casing Solutions, adding cash-and-share funded deals across 2024–2025.
The company designs, manufactures, rents and services mission‑critical downhole tools used across the well lifecycle, with 2025 revenue split between North American and International/Offshore markets and weighted toward product sales. Management estimates an $8.0 billion addressable market and mid‑teens share in North America.
Innovex highlights a “No Barriers” culture, in‑house and outsourced manufacturing across several countries, and a large patent portfolio. The report also emphasizes extensive risk factors tied to oil and gas cyclicality, global expansion, regulation, climate and fracturing policies, supply chain, indebtedness, and compliance with trade and anti‑corruption laws.
INVX disclosure: A Rule 144 notice reports 18,837 common shares to be sold by the reporting person tied to a 01/01/2024 stock award. The filing lists prior permitted sales of 13,241 shares on 01/14/2026 for $331,025.00 and 13,241 shares on 02/23/2026 for $357,507.00. The securities are listed on NYSE and the covering notice is dated 02/24/2026.
Innovex International, Inc. reported strong fourth-quarter and full-year 2025 results, highlighted by Q4 revenue of $273,602,000, up 14% sequentially. Q4 net income was $13,968,000 with a 5% net margin, and Adjusted EBITDA reached $52,108,000 with a 19% margin.
For full-year 2025, revenue grew to $978,251,000 and income from operations was $132,625,000. The company generated Q4 Free Cash Flow of $43,311,000 and $155,780,000 for the year, ending 2025 with $203,407,000 in cash and cash equivalents and no bank debt. Management guided Q1 2026 revenue to $225,000,000–$235,000,000 and Adjusted EBITDA to $38,000,000–$42,000,000, noting lower subsea deliveries and a plan to improve subsea margins after exiting the Eldridge facility by the end of Q2 2026.
Issuer: INVX (NYSE) notice of proposed sale under Rule 144 involving common stock tied to a prior stock award.
Broker is UBS Financial Services, Inc.. The filing shows Adam Anderson reported sales of 331,025 common shares on 01/14/2026, and the securities originate from a stock award dated 12/31/2016.
Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 20,000 shares of common stock on January 14, 2026 at $25 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). After this transaction, he directly beneficially owned 129,436 shares of Innovex International common stock.
Innovex International, Inc. (INVX) Chief Executive Officer and director Adam Anderson reported selling 13,241 shares of common stock on January 14, 2026. The sale, coded as an open market sale, was executed at a price of $25 per share and was carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which is designed to pre-arrange trades. Following this transaction, Anderson directly beneficially owns 498,822 shares of Innovex common stock.
An affiliate of INVX has filed a Form 144 giving notice of a planned sale of 20,000 shares of common stock through UBS Financial Services, Inc. on the NYSE. The filing lists an aggregate market value of $500,000 for these shares, compared with 68,927,791 shares outstanding for the issuer.
The shares to be sold were acquired as a stock award from the issuer on July 3, 2024, in a non-cash transaction described as “N/A” for payment. The approximate date of sale is indicated as January 14, 2026. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
An insider of the issuer filed a Form 144 to potentially sell 13,241 shares of common stock through UBS Financial Services on 01/14/2026 on the NYSE. The filing lists an aggregate market value of $331,025.00 for these shares, compared with 68,927,791 shares outstanding for the issuer’s common stock.
The shares to be sold were originally acquired on 12/31/2016 as a stock award from the issuer, with the full amount of 13,241 shares received on that date. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.